查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589462

糖尿病治療設備市場：按應用、產品和分佈分類 - 全球預測 2025-2030

Diabetes Care Devices Market by Use (Point-of-care, Selftest), Product (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年糖尿病治療設備市場價值為26.2億美元，預計2024年將達31億美元，複合年成長率為18.58%，到2030年將達到86.4億美元。

糖尿病治療設備市場包括血糖監測儀、胰島素輸送設備和糖尿病管理軟體等多種產品，所有這些產品都旨在幫助個人有效管理糖尿病狀況。由於生活方式的改變和肥胖率的增加，全世界糖尿病人口數量不斷增加，因此需要這些設備。應用範圍從血糖值測試和連續血糖監測 (CGM) 到胰島素管理，並用於醫院、診所和居家醫療環境。關鍵的成長要素包括 CGM 系統的技術進步、非侵入性和穿戴式裝置的更多採用以及政府促進糖尿病管理的舉措。此外，提高對糖尿病的認知和教育將進一步擴大市場。將人工智慧和機器學習整合到糖尿病護理設備中可以最佳化個人化醫療和預測分析，這是一項重大商機。公司應該投資研發，創新用戶友善且具成本效益的解決方案，特別是針對醫療基礎設施正在改善的新興市場。然而，先進設備的高成本、嚴格的監管核准以及資料隱私問題等限制因素給市場成長帶來了挑戰。此外，報銷方案很複雜，不同地區之間可能不一致，從而影響採用率。另一個快速發展的領域是混合閉合迴路系統，它代表了未來胰島素管理的重要創新。整體而言，糖尿病治療設備市場充滿活力，透過技術改進、成本降低策略和人口稀少地區的擴張，存在著巨大的成長機會。科技公司和醫療保健提供者之間的合作可以進一步豐富創新管道並有效解決障礙。了解患者需求和監管環境並專注於建立可靠的資料管理框架將是保持長期市場競爭力和成長的關鍵。

主要市場統計
基準年[2023] 26.2億美元
預測年份 [2024] 31億美元
預測年份 [2030] 86.4億美元
複合年成長率（%） 18.58%

市場動態：快速發展的糖尿病治療設備市場的關鍵市場洞察

供需的動態交互作用正在改變糖尿病護理設備市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 糖尿病人口不斷增加，糖尿病治療意識不斷增強
    • 對血糖濃度監測等新技術的需求不斷成長
    • 政府對糖尿病治療的支持措施
  • 市場限制因素
    • 先進醫療設備的高成本
  • 市場機會
    • 自我護理和居家照護的成長趨勢
    • 透過整合先進技術改進功能
  • 市場挑戰
    • 低度開發地區缺乏認知與傳播

波特五力：駕馭糖尿病治療設備市場的策略工具

波特的五力框架是了解糖尿病治療設備市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解糖尿病治療設備市場的外部影響

外部宏觀環境因素在塑造糖尿病治療設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解糖尿病治療設備市場的競爭狀況

對糖尿病治療設備市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣糖尿病治療設備市場供應商的績效評估

FPNV 定位矩陣是評估糖尿病治療設備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃糖尿病治療設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對糖尿病治療設備市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 糖尿病患者數量不斷增加，糖尿病治療意識不斷增強
      • 對血糖值監測等新技術的需求不斷增加
      • 政府對糖尿病照護的支持措施
    • 抑制因素
      • 先進醫療設備的高成本
    • 機會
      • 自我護理和居家照護趨勢增加
      • 透過整合先進技術改進功能
    • 任務
      • 對低度開發地區缺乏認知與滲透
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章糖尿病治療設備市場（按應用）

  • 照護現場
  • 自檢

第7章糖尿病治療設備市場：依產品

  • 血糖值監測裝置
    • 連續血糖監測儀
    • 採血針
    • 自我血糖儀
    • 試紙
  • 胰島素給藥裝置
    • 胰島素噴射注射器
    • 胰島素筆
    • 胰島素幫浦
    • 胰島素注射器

第8章糖尿病治療設備市場經銷商

  • 離線模式
  • 線上模式

第9章北美和南美糖尿病治療設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區糖尿病治療設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的糖尿病治療設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • Arkray, Inc.
  • B. Braun SE
  • Becton, Dickinson, and Company
  • Bionime Corporation
  • DexCom, Inc.
  • Eli Lilly and Company
  • F.Hoffmann-La Roche AG
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Nova Biomedical, Inc.
  • Novo Nordisk A/S
  • Sanofi SA
Product Code: MRR-43539E5D2EA5

The Diabetes Care Devices Market was valued at USD 2.62 billion in 2023, expected to reach USD 3.10 billion in 2024, and is projected to grow at a CAGR of 18.58%, to USD 8.64 billion by 2030.

The diabetes care devices market encompasses a range of products including glucose monitors, insulin delivery devices, and diabetic management software, all aimed at helping individuals manage their diabetic condition effectively. The necessity of these devices stems from the growing diabetic population worldwide, driven by lifestyle changes and an increase in obesity rates. Applications span from blood glucose testing and continuous glucose monitoring (CGM) to insulin administration, which are utilized by hospitals, clinics, and home care settings. Key growth factors include technological advancements in CGM systems, rising adoption of non-invasive and wearable devices, and government initiatives promoting diabetes management. Moreover, increased awareness and education about diabetes lead to further market expansion. One significant opportunity lies in the integration of artificial intelligence and machine learning in diabetes care devices, which can optimize personalized medicine and predictive analytics. Companies should invest in R&D to innovate user-friendly and cost-effective solutions, particularly targeting emerging markets with improving healthcare infrastructure. However, limitations such as the high cost of advanced devices, stringent regulatory approvals, and data privacy concerns pose challenges for market growth. Additionally, the reimbursement scenario can be complex and inconsistent across regions, affecting adoption rates. Another fast-evolving area is the hybrid closed-loop systems, representing a significant innovation for future insulin management. Overall, the diabetes care devices market is dynamic, with considerable opportunity for growth through technological enhancement, cost-reduction strategies, and expansion in underpenetrated regions. Collaboration between technology firms and healthcare providers can further enrich the innovation pipeline and address barriers effectively. Understanding patient needs and regulatory landscapes, while focusing on building robust data management frameworks, will be critical in sustaining long-term market competitiveness and growth.

KEY MARKET STATISTICS
Base Year [2023] USD 2.62 billion
Estimated Year [2024] USD 3.10 billion
Forecast Year [2030] USD 8.64 billion
CAGR (%) 18.58%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diabetes Care Devices Market

The Diabetes Care Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing diabetic population and rising awareness of diabetes treatment
    • Rising need for new technologies such as glucose level monitoring
    • Supportive government initiatives for diabetic care
  • Market Restraints
    • High cost associated with advanced medical devices
  • Market Opportunities
    • Increasing trend of self care or home care
    • Improved functionality with integration of advanced technologies
  • Market Challenges
    • Lack of awareness and penetration in underdeveloped areas

Porter's Five Forces: A Strategic Tool for Navigating the Diabetes Care Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diabetes Care Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diabetes Care Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diabetes Care Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diabetes Care Devices Market

A detailed market share analysis in the Diabetes Care Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diabetes Care Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diabetes Care Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diabetes Care Devices Market

A strategic analysis of the Diabetes Care Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diabetes Care Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acon Laboratories, Inc., AgaMatrix, Inc., Arkray, Inc., B. Braun SE, Becton, Dickinson, and Company, Bionime Corporation, DexCom, Inc., Eli Lilly and Company, F.Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Medtronic PLC, Nova Biomedical, Inc., Novo Nordisk A/S, and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Diabetes Care Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Use, market is studied across Point-of-care and Selftest.
  • Based on Product, market is studied across Blood Glucose Monitoring Devices and Insulin Delivery Devices. The Blood Glucose Monitoring Devices is further studied across Continuous Glucose Monitors, Lancets, Self-Monitoring Blood Glucose Meters, and Testing Strips. The Insulin Delivery Devices is further studied across Insulin Jet Injectors, Insulin Pens, Insulin Pumps, and Insulin Syringes.
  • Based on Distribution, market is studied across Offline Mode and Online Mode.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing diabetic population and rising awareness of diabetes treatment
      • 5.1.1.2. Rising need for new technologies such as glucose level monitoring
      • 5.1.1.3. Supportive government initiatives for diabetic care
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with advanced medical devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing trend of self care or home care
      • 5.1.3.2. Improved functionality with integration of advanced technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness and penetration in underdeveloped areas
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Diabetes Care Devices Market, by Use

  • 6.1. Introduction
  • 6.2. Point-of-care
  • 6.3. Selftest

7. Diabetes Care Devices Market, by Product

  • 7.1. Introduction
  • 7.2. Blood Glucose Monitoring Devices
    • 7.2.1. Continuous Glucose Monitors
    • 7.2.2. Lancets
    • 7.2.3. Self-Monitoring Blood Glucose Meters
    • 7.2.4. Testing Strips
  • 7.3. Insulin Delivery Devices
    • 7.3.1. Insulin Jet Injectors
    • 7.3.2. Insulin Pens
    • 7.3.3. Insulin Pumps
    • 7.3.4. Insulin Syringes

8. Diabetes Care Devices Market, by Distribution

  • 8.1. Introduction
  • 8.2. Offline Mode
  • 8.3. Online Mode

9. Americas Diabetes Care Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Diabetes Care Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Diabetes Care Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Acon Laboratories, Inc.
  • 3. AgaMatrix, Inc.
  • 4. Arkray, Inc.
  • 5. B. Braun SE
  • 6. Becton, Dickinson, and Company
  • 7. Bionime Corporation
  • 8. DexCom, Inc.
  • 9. Eli Lilly and Company
  • 10. F.Hoffmann-La Roche AG
  • 11. Johnson & Johnson Services, Inc.
  • 12. Medtronic PLC
  • 13. Nova Biomedical, Inc.
  • 14. Novo Nordisk A/S
  • 15. Sanofi S.A.

LIST OF FIGURES

  • FIGURE 1. DIABETES CARE DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. DIABETES CARE DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY USE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DIABETES CARE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIABETES CARE DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIABETES CARE DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELFTEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE METERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN JET INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE MODE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ONLINE MODE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY USE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 235. DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. DIABETES CARE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023